Association between FGFR3 and TP53 mutations according to the stage/grade group.

Association between clinic-pathological features and EC patients stratified by genetic mutational profiles.

Tomoko Haruma (4764213)
Takeshi Nagasaka (8474)
Keiichiro Nakamura (4764207)
Junko Haraga (4764204)
Akihiro Nyuya (4764216)
Takeshi Nishida (703341)
Ajay Goel (130080)
Hisashi Masuyama (541901)
Yuji Hiramatsu (541902)

April 2018

Association between clinic-pathological features and EC patients stratified by genetic mutational...

A. Forest plot of the association between DR and the TGFβ1 -509C/T mutation (C vs T).

Lei Liu (5074)
Jinghua Jiao (444675)
Yu Wang (12152)
Jingyang Wu (531657)
Desheng Huang (154084)
Weiping Teng (532328)
Lei Chen (54296)

April 2014

<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0094160#pone-0094160-g003" ...

Association of FGF-2, FGFR-2 and FGFR-3 with clinico-pathological features in OSCC.

Seema Nayak (813016)
Madhu Mati Goel (473426)
Annu Makker (813017)
Vikram Bhatia (406012)
Saumya Chandra (813018)
Sandeep Kumar (145759)
S. P. Agarwal (813019)

October 2015

Association of FGF-2, FGFR-2 and FGFR-3 with clinico-pathological features in OSCC.</p

TP53 mutation rates in FGFR3-wild-type and FGFR3-mutated tumours, according to a combination of stage and grade.

Yann Neuzillet (111802)
Xavier Paoletti (111804)
Slah Ouerhani (111806)
Pierre Mongiat-Artus (42102)
Hany Soliman (111808)
Hugues de The (5648671)
Mathilde Sibony (111811)
Yves Denoux (111813)
Vincent Molinie (111814)
Aurélie Herault (111815)
May-Linda Lepage (111816)
Pascale Maille (111817)
Audrey Renou (111818)
Dimitri Vordos (111819)
Claude-Clément Abbou (111820)
Ashraf Bakkar (111821)
Bernard Asselain (111822)
Nadia Kourda (111824)
Amel El Gaaied (111827)
Karen Leroy (111829)
Agnès Laplanche (111831)
Simone Benhamou (111834)
Thierry Lebret (111837)
Yves Allory (111840)
François Radvanyi (13822)

December 2012

TP53 mutation rates in FGFR3-wild-type and FGFR3-mutated tumours, according to a co...

Combined FGFR3 and TP53 mutation frequencies according to the stage/grade group.

Yann Neuzillet (111802)
Xavier Paoletti (111804)
Slah Ouerhani (111806)
Pierre Mongiat-Artus (42102)
Hany Soliman (111808)
Hugues de The (5648671)
Mathilde Sibony (111811)
Yves Denoux (111813)
Vincent Molinie (111814)
Aurélie Herault (111815)
May-Linda Lepage (111816)
Pascale Maille (111817)
Audrey Renou (111818)
Dimitri Vordos (111819)
Claude-Clément Abbou (111820)
Ashraf Bakkar (111821)
Bernard Asselain (111822)
Nadia Kourda (111824)
Amel El Gaaied (111827)
Karen Leroy (111829)
Agnès Laplanche (111831)
Simone Benhamou (111834)
Thierry Lebret (111837)
Yves Allory (111840)
François Radvanyi (13822)

December 2012

Proportion of tumours with both FGFR3 and TP53 mutations (orange), with FGFR3</i...

Combined FGFR3 and TP53 mutation frequencies by stage (pT).

Yann Neuzillet (111802)
Xavier Paoletti (111804)
Slah Ouerhani (111806)
Pierre Mongiat-Artus (42102)
Hany Soliman (111808)
Hugues de The (5648671)
Mathilde Sibony (111811)
Yves Denoux (111813)
Vincent Molinie (111814)
Aurélie Herault (111815)
May-Linda Lepage (111816)
Pascale Maille (111817)
Audrey Renou (111818)
Dimitri Vordos (111819)
Claude-Clément Abbou (111820)
Ashraf Bakkar (111821)
Bernard Asselain (111822)
Nadia Kourda (111824)
Amel El Gaaied (111827)
Karen Leroy (111829)
Agnès Laplanche (111831)
Simone Benhamou (111834)
Thierry Lebret (111837)
Yves Allory (111840)
François Radvanyi (13822)

December 2012

Proportion of tumours with both FGFR3 and TP53 mutations (orange), with mutated ...

Associations of TP53 mutations with estimates of immune cell levels across TCGA cohorts.

Nathan O. Siemers (216820)
James L. Holloway (4281808)
Han Chang (101808)
Scott D. Chasalow (4281811)
Petra B. Ross-MacDonald (4281805)
Charles F. Voliva (2160919)
Joseph D. Szustakowski (195929)

July 2017

Associations of TP53 mutations with estimates of immune cell levels across TCGA cohorts.</p

Distribution of TP53 and FGFR3 somatic mutations in relation to tumor morphology and histology.

Alessandro Apollo (3842275)
Valerio Ortenzi (2037904)
Cristian Scatena (2037901)
Katia Zavaglia (5768015)
Paolo Aretini (3577613)
Francesca Lessi (238026)
Sara Franceschi (3577601)
Sara Tomei (3441323)
Carlo Alberto Sepich (6236564)
Paolo Viacava (6236567)
Chiara Maria Mazzanti (3842278)
Antonio Giuseppe Naccarato (2037895)

January 2019

Distribution of TP53 and FGFR3 somatic mutations in relation to tumor morphology and histology.</p

A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.

Yann Neuzillet
Xavier Paoletti
Slah Ouerhani
Pierre Mongiat-Artus
Hany Soliman
Hugues de The
Mathilde Sibony
Yves Denoux
Vincent Molinie
Aurélie Herault
May-Linda Lepage
Pascale Maille
Audrey Renou
Dimitri Vordos
Claude-Clément Abbou
Ashraf Bakkar
Bernard Asselain
Nadia Kourda
Amel El Gaaied
Karen Leroy
Agnès Laplanche
Simone Benhamou
Thierry Lebret
Yves Allory
François Radvanyi

TP53 and FGFR3 mutations are the most common mutations in bladder cancers. FGFR3 mutations are most ...

A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer

Yann Neuzillet (111802)
Xavier Paoletti (111804)
Slah Ouerhani (111806)
Pierre Mongiat-Artus (42102)
Hany Soliman (111808)
Hugues de The (5648671)
Mathilde Sibony (111811)
Yves Denoux (111813)
Vincent Molinie (111814)
Aurélie Herault (111815)
May-Linda Lepage (111816)
Pascale Maille (111817)
Audrey Renou (111818)
Dimitri Vordos (111819)
Claude-Clément Abbou (111820)
Ashraf Bakkar (111821)
Bernard Asselain (111822)
Nadia Kourda (111824)
Amel El Gaaied (111827)
Karen Leroy (111829)
Agnès Laplanche (111831)
Simone Benhamou (111834)
Thierry Lebret (111837)
Yves Allory (111840)
François Radvanyi (13822)

December 2012

<div>TP53 and FGFR3 mutations are the most common mutations in bladder cancers....

Correlation between the T/N expression level of FHL2 and coding region mutations of TP53 in HCC samples.

Jiaying Xu (443374)
Junwei Zhou (615666)
Man-Shan Li (347605)
Chor-Fung Ng (615667)
Yuen-Keng Ng (615668)
Paul Bo-San Lai (5649874)
Stephen Kwok-Wing Tsui (292576)

August 2014

Correlation between the T/N expression level of FHL2 and coding region mutations of TP53 in HCC s...

Correlations between TP53 mutational status and clinicopathological parameters.

Zahra Fathi (5562713)
Seyed Ali Javad Mousavi (5562716)
Raheleh Roudi (5562719)
Farideh Ghazi (5562722)

July 2018

Correlations between TP53 mutational status and clinicopathological parameters.</p

Associations between genotyped variants identified from sequencing brought forward to the entire FHS sample.

Anna Köttgen (3111024)
Qiong Yang (28822)
Lawrence C. Shimmin (160755)
Adrienne Tin (160761)
Céline Schaeffer (160768)
Josef Coresh (93441)
Xuan Liu (49954)
Luca Rampoldi (160772)
Shih-Jen Hwang (79945)
Eric Boerwinkle (36288)
James E. Hixson (136674)
W. H. Linda Kao (160779)
Caroline S. Fox (110474)

May 2012

Associations between genotyped variants identified from sequencing brought forward to the entire ...

Significant associations between mutational signatures and driver mutations within individual cancer types, alongside proposed aetiology and frequency of the trinucleotide context in the associated mutational signature.

Rebecca C. Poulos (5949539)
Yuen T. Wong (5949542)
Regina Ryan (5949545)
Herbert Pang (3321591)
Jason W. H. Wong (2131438)

November 2018

Significant associations between mutational signatures and driver mutations within individual cancer...

Association between clinicopathological parameters, mtDNA haplogroup, TP53 R72P polymorphism and somatic mtDNA mutation frequency.

Chih-Hsiung Lai (117103)
Shiang-Fu Huang (117106)
Chun-Ta Liao (117115)
I-How Chen (117112)
Hung-Ming Wang (117121)
Ling-Ling Hsieh (117126)

June 2013

Association between clinicopathological parameters, mtDNA haplogroup, TP53 R72P polymorphi...

Association between clinic-pathological features and EC patients stratified by genetic mutational profiles.

Tomoko Haruma (4764213)
Takeshi Nagasaka (8474)
Keiichiro Nakamura (4764207)
Junko Haraga (4764204)
Akihiro Nyuya (4764216)
Takeshi Nishida (703341)
Ajay Goel (130080)
Hisashi Masuyama (541901)
Yuji Hiramatsu (541902)

April 2018

Association between clinic-pathological features and EC patients stratified by genetic mutational...

A. Forest plot of the association between DR and the TGFβ1 -509C/T mutation (C vs T).

Lei Liu (5074)
Jinghua Jiao (444675)
Yu Wang (12152)
Jingyang Wu (531657)
Desheng Huang (154084)
Weiping Teng (532328)
Lei Chen (54296)

April 2014

<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0094160#pone-0094160-g003" ...

Association of FGF-2, FGFR-2 and FGFR-3 with clinico-pathological features in OSCC.

Seema Nayak (813016)
Madhu Mati Goel (473426)
Annu Makker (813017)
Vikram Bhatia (406012)
Saumya Chandra (813018)
Sandeep Kumar (145759)
S. P. Agarwal (813019)

October 2015

Association of FGF-2, FGFR-2 and FGFR-3 with clinico-pathological features in OSCC.</p

TP53 mutation rates in FGFR3-wild-type and FGFR3-mutated tumours, according to a combination of stage and grade.

Yann Neuzillet (111802)
Xavier Paoletti (111804)
Slah Ouerhani (111806)
Pierre Mongiat-Artus (42102)
Hany Soliman (111808)
Hugues de The (5648671)
Mathilde Sibony (111811)
Yves Denoux (111813)
Vincent Molinie (111814)
Aurélie Herault (111815)
May-Linda Lepage (111816)
Pascale Maille (111817)
Audrey Renou (111818)
Dimitri Vordos (111819)
Claude-Clément Abbou (111820)
Ashraf Bakkar (111821)
Bernard Asselain (111822)
Nadia Kourda (111824)
Amel El Gaaied (111827)
Karen Leroy (111829)
Agnès Laplanche (111831)
Simone Benhamou (111834)
Thierry Lebret (111837)
Yves Allory (111840)
François Radvanyi (13822)

December 2012

TP53 mutation rates in FGFR3-wild-type and FGFR3-mutated tumours, according to a co...

Combined FGFR3 and TP53 mutation frequencies according to the stage/grade group.

Yann Neuzillet (111802)
Xavier Paoletti (111804)
Slah Ouerhani (111806)
Pierre Mongiat-Artus (42102)
Hany Soliman (111808)
Hugues de The (5648671)
Mathilde Sibony (111811)
Yves Denoux (111813)
Vincent Molinie (111814)
Aurélie Herault (111815)
May-Linda Lepage (111816)
Pascale Maille (111817)
Audrey Renou (111818)
Dimitri Vordos (111819)
Claude-Clément Abbou (111820)
Ashraf Bakkar (111821)
Bernard Asselain (111822)
Nadia Kourda (111824)
Amel El Gaaied (111827)
Karen Leroy (111829)
Agnès Laplanche (111831)
Simone Benhamou (111834)
Thierry Lebret (111837)
Yves Allory (111840)
François Radvanyi (13822)

December 2012

Proportion of tumours with both FGFR3 and TP53 mutations (orange), with FGFR3</i...

Combined FGFR3 and TP53 mutation frequencies by stage (pT).

Yann Neuzillet (111802)
Xavier Paoletti (111804)
Slah Ouerhani (111806)
Pierre Mongiat-Artus (42102)
Hany Soliman (111808)
Hugues de The (5648671)
Mathilde Sibony (111811)
Yves Denoux (111813)
Vincent Molinie (111814)
Aurélie Herault (111815)
May-Linda Lepage (111816)
Pascale Maille (111817)
Audrey Renou (111818)
Dimitri Vordos (111819)
Claude-Clément Abbou (111820)
Ashraf Bakkar (111821)
Bernard Asselain (111822)
Nadia Kourda (111824)
Amel El Gaaied (111827)
Karen Leroy (111829)
Agnès Laplanche (111831)
Simone Benhamou (111834)
Thierry Lebret (111837)
Yves Allory (111840)
François Radvanyi (13822)

December 2012

Proportion of tumours with both FGFR3 and TP53 mutations (orange), with mutated ...

Associations of TP53 mutations with estimates of immune cell levels across TCGA cohorts.

Nathan O. Siemers (216820)
James L. Holloway (4281808)
Han Chang (101808)
Scott D. Chasalow (4281811)
Petra B. Ross-MacDonald (4281805)
Charles F. Voliva (2160919)
Joseph D. Szustakowski (195929)

July 2017

Associations of TP53 mutations with estimates of immune cell levels across TCGA cohorts.</p

Distribution of TP53 and FGFR3 somatic mutations in relation to tumor morphology and histology.

Alessandro Apollo (3842275)
Valerio Ortenzi (2037904)
Cristian Scatena (2037901)
Katia Zavaglia (5768015)
Paolo Aretini (3577613)
Francesca Lessi (238026)
Sara Franceschi (3577601)
Sara Tomei (3441323)
Carlo Alberto Sepich (6236564)
Paolo Viacava (6236567)
Chiara Maria Mazzanti (3842278)
Antonio Giuseppe Naccarato (2037895)

January 2019

Distribution of TP53 and FGFR3 somatic mutations in relation to tumor morphology and histology.</p

A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.

Yann Neuzillet
Xavier Paoletti
Slah Ouerhani
Pierre Mongiat-Artus
Hany Soliman
Hugues de The
Mathilde Sibony
Yves Denoux
Vincent Molinie
Aurélie Herault
May-Linda Lepage
Pascale Maille
Audrey Renou
Dimitri Vordos
Claude-Clément Abbou
Ashraf Bakkar
Bernard Asselain
Nadia Kourda
Amel El Gaaied
Karen Leroy
Agnès Laplanche
Simone Benhamou
Thierry Lebret
Yves Allory
François Radvanyi

TP53 and FGFR3 mutations are the most common mutations in bladder cancers. FGFR3 mutations are most ...

A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer

Yann Neuzillet (111802)
Xavier Paoletti (111804)
Slah Ouerhani (111806)
Pierre Mongiat-Artus (42102)
Hany Soliman (111808)
Hugues de The (5648671)
Mathilde Sibony (111811)
Yves Denoux (111813)
Vincent Molinie (111814)
Aurélie Herault (111815)
May-Linda Lepage (111816)
Pascale Maille (111817)
Audrey Renou (111818)
Dimitri Vordos (111819)
Claude-Clément Abbou (111820)
Ashraf Bakkar (111821)
Bernard Asselain (111822)
Nadia Kourda (111824)
Amel El Gaaied (111827)
Karen Leroy (111829)
Agnès Laplanche (111831)
Simone Benhamou (111834)
Thierry Lebret (111837)
Yves Allory (111840)
François Radvanyi (13822)

December 2012

<div>TP53 and FGFR3 mutations are the most common mutations in bladder cancers....

Correlation between the T/N expression level of FHL2 and coding region mutations of TP53 in HCC samples.

Jiaying Xu (443374)
Junwei Zhou (615666)
Man-Shan Li (347605)
Chor-Fung Ng (615667)
Yuen-Keng Ng (615668)
Paul Bo-San Lai (5649874)
Stephen Kwok-Wing Tsui (292576)

August 2014

Correlation between the T/N expression level of FHL2 and coding region mutations of TP53 in HCC s...

Correlations between TP53 mutational status and clinicopathological parameters.

Zahra Fathi (5562713)
Seyed Ali Javad Mousavi (5562716)
Raheleh Roudi (5562719)
Farideh Ghazi (5562722)

July 2018

Correlations between TP53 mutational status and clinicopathological parameters.</p

Associations between genotyped variants identified from sequencing brought forward to the entire FHS sample.

Anna Köttgen (3111024)
Qiong Yang (28822)
Lawrence C. Shimmin (160755)
Adrienne Tin (160761)
Céline Schaeffer (160768)
Josef Coresh (93441)
Xuan Liu (49954)
Luca Rampoldi (160772)
Shih-Jen Hwang (79945)
Eric Boerwinkle (36288)
James E. Hixson (136674)
W. H. Linda Kao (160779)
Caroline S. Fox (110474)

May 2012

Associations between genotyped variants identified from sequencing brought forward to the entire ...

Significant associations between mutational signatures and driver mutations within individual cancer types, alongside proposed aetiology and frequency of the trinucleotide context in the associated mutational signature.

Rebecca C. Poulos (5949539)
Yuen T. Wong (5949542)
Regina Ryan (5949545)
Herbert Pang (3321591)
Jason W. H. Wong (2131438)

November 2018

Significant associations between mutational signatures and driver mutations within individual cancer...

Association between clinicopathological parameters, mtDNA haplogroup, TP53 R72P polymorphism and somatic mtDNA mutation frequency.

Chih-Hsiung Lai (117103)
Shiang-Fu Huang (117106)
Chun-Ta Liao (117115)
I-How Chen (117112)
Hung-Ming Wang (117121)
Ling-Ling Hsieh (117126)

June 2013

Association between clinicopathological parameters, mtDNA haplogroup, TP53 R72P polymorphi...

Association between clinic-pathological features and EC patients stratified by genetic mutational profiles.

Tomoko Haruma (4764213)
Takeshi Nagasaka (8474)
Keiichiro Nakamura (4764207)
Junko Haraga (4764204)
Akihiro Nyuya (4764216)
Takeshi Nishida (703341)
Ajay Goel (130080)
Hisashi Masuyama (541901)
Yuji Hiramatsu (541902)

April 2018

Association between clinic-pathological features and EC patients stratified by genetic mutational...

A. Forest plot of the association between DR and the TGFβ1 -509C/T mutation (C vs T).

Lei Liu (5074)
Jinghua Jiao (444675)
Yu Wang (12152)
Jingyang Wu (531657)
Desheng Huang (154084)
Weiping Teng (532328)
Lei Chen (54296)

April 2014

<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0094160#pone-0094160-g003" ...

Association of FGF-2, FGFR-2 and FGFR-3 with clinico-pathological features in OSCC.

Seema Nayak (813016)
Madhu Mati Goel (473426)
Annu Makker (813017)
Vikram Bhatia (406012)
Saumya Chandra (813018)
Sandeep Kumar (145759)
S. P. Agarwal (813019)

October 2015

Association of FGF-2, FGFR-2 and FGFR-3 with clinico-pathological features in OSCC.</p

Association between <i>FGFR3</i> and <i>TP53</i> mutations according to the stage/grade group.

Abstract

Extracted data

Association between <i>FGFR3</i> and <i>TP53</i> mutations according to the stage/grade group.

Abstract

Extracted data

Related items

Related items